Galanthamine, a prominent alkaloid predominately isolated from plants within the Amaryllidaceae family (Harvey, 1995), is renowned for its role in Alzheimer’s disease therapy through the inhibition of cholinesterase enzymes (Sharma, 2019). Here, BCHE is linked to early-onset autosomal dominant Alzheimer disease.